Today, we took long-overdue action to restore science, accountability, and the rule of law.
In September 2023, the Biden FDA pushed a number of peptides into Category 2 — “Bulk Drug Substances that Raise Significant Safety Risks” — driving a dangerous black market that puts Americans at risk.
Now, after nominators withdrew 12 peptides, the FDA will remove them from Category 2 and will bring them to PCAC at its next two meetings, beginning in July—where independent experts will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence.
• BPC-157
• Thymosin beta-4 fragment (LKKTETQ)
• Epitalon
• GHK-Cu (injectable)
• MOTS-c
• DSIP (Emideltide)
• Dihexa Acetate
• Ibutamoren Mesylate
• Melanotan II
• KPV
• Semax (heptapeptide)
• Cathelicidin LL-37
This action begins to restore regulated access and will immediately begin shifting demand away from the black market.
We will follow the science, enforce the law, and deliver the clarity patients, providers, and pharmacies deserve.
2026 is going to be a great year for @vergecurrency
As the greater public is starting to understand what $XVG stands for.
Since 2014, @justinvendetta has not missed a beat. He has only gotten stronger with his message. 2025 was a benchmark year for the Ecosystem.
2026 will welcome many many more people into the ecosystem, with more growth and certainty.
Looking forward to it.
This is another clip from the same rocket launch. If you look closely to the right of the rocket in the plume, also called the jellyfish🪼, you can see the booster that detached.